INS and type 2 diabetes mellitus: Compared to T2DM patients who received pioglitazone, both insulin-induced Aβ accumulation in the brain and peripheral insulin resistance-impaired brain insulin signalling are possible mechanisms in T2DM patients who are receiving both pioglitazone and insulin.